(Q43718408)

26 November 2017

title

Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II. (English)

1 reference

Human T-lymphotropic virus 1

26 November 2017

main subject

0 references

author name string

Andersson S

series ordinal

1

1 reference

26 November 2017

Gessain A

series ordinal

2

1 reference

26 November 2017

Taylor GP

series ordinal

3

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

78

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

101-106

1 reference

Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Spastic ataxia associated with human T-cell lymphotropic virus type II infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Pooling blood donor samples to reduce the cost of HIV-1 antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Are seroepidemiological surveys for human immunodeficiency virus infection based on tests on pools of serum specimens accurate and cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Reducing the cost of HIV antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

High Prevalence of Human T Cell Lymphotropic Virus Type II Infection in Patients Affected by Human Immunodeficiency Virus Type 1-Associated Predominantly Sensory Polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900289-1

7 January 2021

10.1016/S0168-1702(01)00289-1

Identifiers

DOI

1 reference

26 November 2017

1 reference